The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Location status: Recruiting
NCT Number: NCT06766630
Rotator cuff tears result in shoulder joint pain and movement disorders, affecting patients' daily lives. The incidence rate rises with age and can be as high as 54% among people over 60 years old. Most rotator cuff tears are unable to heal spontaneously, and the tear area may gradually expand over time. Currently, the main surgical treatment for rotator cuff tears is to use suture anchors to stitch the rotator cuff tendon tissue back to the original anatomical insertion point. Large rotator cuff tears are often accompanied by fat infiltration and tendon retraction. When forcefully sutured, the tension is relatively high, which may lead to non-healing and re-tearing of the rotator cuff. Research indicates that the re-tear rate after rotator cuff tear repair is 20% - 30%, and this probability can reach 40% - 50% for large rotator cuff tears. For these irreparable and large tears, rotator cuff repair typically requires patch augmentation techniques. Surgeries are based on restoring the force couple effect of the rotator cuff as much as possible and covering it with repair materials to achieve reinforcement. Silk fibroin surgical mesh is made of silk fibroin which has good biocompatibility and can be generally placed in the area of rotator cuff tears that cannot be repaired through conventional surgeries. By providing support to the injured rotator cuff tissue, it improves the repair effect. It can reestablish the integrity of the rotator cuff, reducing mechanical tension at the repair site and maintaining the stability of the glenohumeral joint. Besides, it can also promote tissue healing, and cell infiltration and growth, thereby facilitating the biological repair of the injured rotator cuff and reducing the occurrence of postoperative re-tears.
Interested in participating?
Request Info50 year–75 year
All sexes
Interventional
Phase 2 / Phase 3
Hangzhou, Zhejiang, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Intraoperative:
Exclusion criteria
This product is a mesh patch made of mulberry silk by warp knitting and degumming. The main component is fibroin protein
Time frame: From enrollment to the end of treatment at 12 months
Time frame: From enrollment to 6 months after surgery
Time frame: From enrollment to the end of treatment at 12 months
Time frame: From enrollment to the end of treatment at 12 months
Time frame: From enrollment to the end of treatment at 12 months
Time frame: From enrollment to the end of treatment at 12 months
Time frame: From enrollment to the end of treatment at 12 months
Contact information is provided by the study sponsor or research team.
Weiliang Shen, Ph.D., M.D.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03617562
Rotator Cuff Injuries, Rotator Cuff Tear
Toronto, Ontario, Canada
View Trial DetailsNCT06918041
Rotator Cuff Injuries, Rotator Cuff Tear
Chicago, Illinois, United States
View Trial DetailsNCT05906004
Rotator Cuff Injuries, Rotator Cuff Tear
Reading, United Kingdom
View Trial DetailsNCT07558590
Arthritis, Avascular Necrosis of the Head of Humerus
Amiens, France
View Trial Details